Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 127.03
-6.96 (-5.19%)
At close: Jan 20, 2026
Anlon Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,438 | 1,203 | 665.84 | 1,129 | 571.43 | 159.8 |
Other Revenue | 0.47 | 0.47 | 0.33 | 2.02 | 2.46 | - |
| 1,438 | 1,203 | 666.16 | 1,131 | 573.89 | 159.8 | |
Revenue Growth (YoY) | 115.91% | 80.64% | -41.09% | 97.04% | 259.14% | - |
Cost of Revenue | 910.92 | 752.26 | 348.75 | 888.76 | 438.05 | 124.97 |
Gross Profit | 527.41 | 451.07 | 317.42 | 242.04 | 135.84 | 34.82 |
Selling, General & Admin | 64.62 | 65.86 | 62.45 | 42.51 | 32.59 | 31.59 |
Other Operating Expenses | 79.85 | 57.57 | 97.34 | 68.22 | 44.62 | 54.93 |
Operating Expenses | 161.53 | 141.18 | 178.66 | 129.39 | 95.64 | 105.11 |
Operating Income | 365.88 | 309.9 | 138.75 | 112.65 | 40.2 | -70.29 |
Interest Expense | -35.39 | -37.7 | -40.77 | -37.89 | -41.06 | -31.71 |
Interest & Investment Income | 0.81 | 0.81 | 0.76 | - | - | 1.31 |
Currency Exchange Gain (Loss) | -1.3 | -1.3 | -0.32 | -3.82 | -0.07 | 2.19 |
Other Non Operating Income (Expenses) | -3.46 | -2.78 | -0.92 | -1.01 | -0.15 | -0.42 |
EBT Excluding Unusual Items | 326.55 | 268.94 | 97.51 | 69.93 | -1.08 | -98.91 |
Gain (Loss) on Sale of Assets | -0.06 | -0.06 | - | - | - | - |
Other Unusual Items | - | - | - | - | - | -0.18 |
Pretax Income | 326.49 | 268.88 | 97.51 | 69.93 | -1.08 | -99.08 |
Income Tax Expense | 56.23 | 63.7 | 0.94 | 11.73 | - | 3.32 |
Net Income | 270.26 | 205.18 | 96.57 | 58.2 | -1.08 | -102.41 |
Net Income to Common | 270.26 | 205.18 | 96.57 | 58.2 | -1.08 | -102.41 |
Net Income Growth | 179.86% | 112.46% | 65.93% | - | - | - |
Shares Outstanding (Basic) | 41 | 32 | 14 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 41 | 32 | 14 | 12 | 12 | 12 |
Shares Change (YoY) | 182.11% | 123.02% | 20.43% | - | -0.05% | - |
EPS (Basic) | 6.63 | 6.37 | 6.68 | 4.85 | -0.09 | -8.53 |
EPS (Diluted) | 6.63 | 6.37 | 6.68 | 4.85 | -0.09 | -8.53 |
EPS Growth | -0.76% | -4.70% | 37.73% | - | - | - |
Free Cash Flow | - | -230.81 | -67.58 | -32.22 | -22.32 | -152.93 |
Free Cash Flow Per Share | - | -7.16 | -4.68 | -2.69 | -1.86 | -12.74 |
Gross Margin | 36.67% | 37.48% | 47.65% | 21.40% | 23.67% | 21.79% |
Operating Margin | 25.44% | 25.75% | 20.83% | 9.96% | 7.00% | -43.99% |
Profit Margin | 18.79% | 17.05% | 14.50% | 5.15% | -0.19% | -64.09% |
Free Cash Flow Margin | - | -19.18% | -10.14% | -2.85% | -3.89% | -95.70% |
EBITDA | 382.95 | 327.64 | 157.63 | 131.31 | 58.62 | -51.7 |
EBITDA Margin | 26.63% | 27.23% | 23.66% | 11.61% | 10.21% | -32.36% |
D&A For EBITDA | 17.07 | 17.74 | 18.88 | 18.66 | 18.42 | 18.58 |
EBIT | 365.88 | 309.9 | 138.75 | 112.65 | 40.2 | -70.29 |
EBIT Margin | 25.44% | 25.75% | 20.83% | 9.96% | 7.00% | -43.99% |
Effective Tax Rate | 17.22% | 23.69% | 0.96% | 16.78% | - | - |
Revenue as Reported | 1,439 | 1,205 | 666.92 | 1,131 | 575.36 | 163.3 |
Advertising Expenses | - | 0.07 | - | - | - | 0.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.